Substance abuse treatment entry, retention and effectiveness: Out-of-treatment opiate injection drug users

Drug and Alcohol Dependence

Volumn 42, Issue 1, 1996, Pages 11-20

  Booth, Robert E ^a   Crowley, Thomas J ^a   Zhang, Yiming ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Drug use; HIV; IDU; Treatment

Indexed keywords

COCAINE; OPIATE;

ADULT; ARTICLE; CLINICAL TRIAL; COMMUNITY CARE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRIME; DRUG DEPENDENCE TREATMENT; DRUG USE; FEMALE; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPIATE ADDICTION; PATIENT COUNSELING; PATIENT REFERRAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030247183     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/0376-8716(96)01257-4     Document Type: Article

References (59)

1. Agosti, V., Nunes, E., Stewart, J.W. and Quitkin, F.M. (1991) Patient factors related to early attrition from an outpatient cocaine research clinic: a preliminary report. Int. J. Addict. 26, 327-334.
2. Anderson, M.D., Smereck, G.A. and Braunstein, M.S. (1993) LIGHT model: an effective intervention model to change high-risk AIDS behavior among hard-to-reach urban drug users. Am. J. Drug. Alcohol Abuse 19, 309-325.
3. Bale, R.N., Van Stone, W.W., Kuldau, J.M., Engelsing, T.M., Elashoff, R.M. and Zarcone, V.P. (1980) Therapeutic communities versus methadone maintenance. A prospective controlled study of narcotic addiction treatment: design and one-year follow-up. Arch. Gen. Psychiatry 37, 179-193.
4. Ball, C.C., Lange, W.R., Myers, C.P. and Friedman, S.R. (1988) Reducing the risk of AIDS through methadone maintenance treatment. J. Health Soc. Beh. 29, 214-226.
5. Battjes, R.J. and Pickens, R.W. (1993) Trends in HIV infection and AIDS risk behaviours among injecting drug users in selected US cities. IX International Conference on AIDS, Berlin, Abstract PO-C15-2950.
6. Booth, R.E. (1994) Predictors of unsafe needle practices: injection drug users in Denver. J. of Acquir. Immun. Defic. Syndr. 7, 504-508.
7. Booth, R.E. and Wiebel, W.W. (1992) The effectiveness of reducing needle-related risks for HIV through indigenous outreach to injection drug users. Am. J. Addict. 1, 277-288.
8. Campbell, C.A. (1990) Women and AIDS. Soc. Sci. Med. 30, 407-415.
9. Centers for Disease Control and Prevention (1990) HIV Monthly Surveillance Report, MMWR.
10. Centers for Disease Control and Prevention (1993) HIV Monthly Surveillance Report, MMWR.
11. Chaisson, R.E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M.A. and Moss, A.R. (1989) Cocaine use and HIV infection in intravenous drug users in San Francisco. J. Am. Med. Assoc. 261, 5615.
12. Coombs, R.H. (1981) Back on the streets: therapeutic communities impact upon drug users. Am. J. Drug Alcohol Abuse 8, 185-201.
13. DeLeon, G., Andrews, M., Wexler, H.K. et al (1979) Therapeutic community dropouts: criminal behavior five years after treatment. Am. J. Drug Alcohol Abuse 6, 253-271.
14. Des Jarlais, D.C. and Friedman, S.R. (1987) HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS 1, 67-76.
15. Des Jarlais, D.C., Joseph, H. and Dole, V.P. (1981) Longterm outcomes after termination from methadone maintenance treatment. Ann. NY Acad. Sci. 362, 231-238.
16. Des Jarlais, D.C., Friedman, S.R. and Stoneburner, R.L. (1988) HIV infection and intravenous drug use: critical issues in transmission dynamics, infection outcome, and prevention. Rev. Infect. Dis. 10, 151-158.
17. Des Jarlais, D.C., Friedman, S.R., Novick, D. et al (1989) HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987. J. Am. Med. Assoc. 261, 1008-1012.
18. Des Jarlais, D.C., Friedman, S.R. and Casriel, C. (1990) Target groups for preventing AIDS among intravenous drug users. II. The 'hard' data studies. J. Consult. Clin. Psychol. 58, 50-56.
19. Des Jarlais, D.C., Abdul-Quader, A. and Tross, S. (1991) The next problem: maintenance of AIDS risk reduction among intravenous drug users. Int. J. Addict. 26, 1279-1292.
20. Dowling, S., Johnson, M.E., Fisher, D.G. et al (1994) Reliability of drug users self-reported recent drug use. Assessment 1, 383-392.
21. Friedland, G.H. and Klein, R.S. (1987) Transmission of the human immunodeficiency virus, N. Engl. J. Med. 317, 1125-1135.
22. Friedman, S.R., Rodriguez, A., Zunzunegui, V. et al. (1993) Similarities in syringe sharing among drug injectors in Madrid and New York City. American Public Health Association Annual Meeting, San Francisco.
23. Gainey, R.R., Wells, E.A., Hawkins, J.D. and Catalano, R.F. (1993) Predicting treatment retention among cocaine users. Int. J. Addict 28, 487-505.
24. Gawin, F.H. and Kleber, H.D. (1994) Cocaine abuse treatment: open trial with desipramine and lithium carbonate. Arch. Gen. Psychiatry 41, 905.
25. Guinan, M.E. and Hardy, A. (1987) Epidemiology of AIDS in women in the United States, 1981 through 1986. J. Am. Med. Assoc. 257, 19-22.
26. Guydish, J.R., Abramowitz, A., Woods, W., Black, D.M. and Sorenson, J.L. (1990) Changes in needle sharing among intravenous drug users: San Francisco, 1986-1988. Am. J. Public Health 80, 995-997.
27. Hubbard, R.L., Marsden, M.E., Cavanaugh, E., Rachal, J.V., Ginzberg, H.M. (1988) Role of drug abuse treatment in limiting the spread of AIDS. Rev. Infect. Dis. 10, 377-384.
28. Kleinman, P.H., Friedman, S.T., Mauge, C.E., Goldsmith, D.S., Des Jarlais, D.C. and Hopkins, W. (1987) Beliefs and behaviours regarding AIDS: a survey of street intravenous drug users about AIDS prevention. III International Conference on AIDS, Washington, DC.
29. Kleinman, P.H., Kang, S.-Y., Lipton, D.S., Woody, G.E., Kemp, J. and Millman, R.B. (1992) Retention of cocaine abusers in outpatient psychotherapy. Am. J. Drug Alcohol Abuse 18, 29-43.
30. McCall, M.E., Stitzer, M.L., Bigelow, G.E. and Liebson, J.A. (1984) Contingency management interventions: effects on treatment outcome during methadone detoxification. J. Appl. Behav. Anal. 17, 35-43.
31. Miller, W.R. and Rollnick, S. (1991) Motivational Interviewing: Preparing People to Change Addictive Behaviours. Guilford Press, New York.
32. Moss, A.R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J. and Osmond, D. (1994) HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS 8, 223-231.
33. National Institute on Drug Abuse (1989) A Cooperative Agreement for AIDS Community-Based Outreach/Intervention Research. Program Announcement DA 90-02. Department of Health and Health and Human Services, Public Health Service.
34. National Institute on Drug Abuse National Institute of Health (1992) The Standard Intervention of the Cooperative Agreement Program for Community-Based Outreach/Intervention Research. Department of Health and Health and Human Services, Public Health Service.
35. National Institute on Drug Abuse National Institute of Health. (1995) Cooperative Agreement for AIDS Community-Based Outreach/Intervention Research Program, 1990-Present. Community Research Branch, Division of Epidemiology and Prevention Research, Department of Health and Health and Human Services, Public Health Service.
36. Neaigus, A., Sufian, M., Friedman, S.R. et al (1990) Effects of outreach intervention on risk reduction among intravenous drug users. AIDS 2, 253-271.
37. Ravndal, E. and Vaglum, P. (1992) Different intake procedures: the influence of treatment start and treatment response - a quasi-experimental study. J. Subst. Abuse. Treat. 9, 53-58.
38. Rollnick, S., Heather, N. and Bell, A. (1992) Negotiating behaviours change in medical settings: the development of brief motivational interviewing. J. Mental Health 1, 25-37.
39. SAS Institute. Inc. (1992) The SAS System for Windows 3.10, Release 6.08. Cary, NC.
40. Schuster, C.R. (1988) Intravenous drug use and AIDS prevention. Public Health Rep. 103, 261-266.
41. Schutz, C.G., Rapiti, E., Vlahov, D. and Anthony, J.C. (1994) Suspected determinants of enrolment into detoxification and methadone maintenance treatment among injecting drug users. Drug Alcohol Depend. 36, 129-138.
42. Selwin, P.A., Feiner, C., Cox, C.P., Lipshutz, C. and Cohen, R.L. (1987) Knowledge about AIDS and high-risk behavior among intravenous drug users in New York City. AIDS 1, 247-254.
43. Siegal, H.A., Falck, R.S., Carlson, R.G. and Ling, L. (1991) Changes in needle risk behaviours: a preliminary comparative analysis of the Dayton-Columbus NADR program's standard and enhanced intervention tracks at six months. Research in Progress, NOVA Research Co., Washington, DC, October, pp. 12-16.
44. Simpson, D.D. (1979) The relation of time spent in drug abuse treatment to post-treatment outcome. Am. J. Psychiatry 136, 1449-1453.
45. Simpson, D.D. (1981) Treatment from drug abuse: follow-up outcomes and length of time spent. Arch. Gen. Psychiatry 38, 875-880.
46. Simpson, D.D. and Sells, S.B. (1981) Highlights of the DARP Follow-up Research on the Evaluation of Drug Abuse Treatment Effectiveness. Institute of Behavioral Research, Texas Christian University, Fort Worth, TX.
47. Simpson, D.D., Savage, L.V. and Lloyd, M.R. (1979) Follow-up evaluation of drug abuse during 1969 to 1972. Arch. Gen. Psychiatry 36, 772-780.
48. Stark, M.J. (1992) Dropping out if substance abuse treatment: a clinically oriented review. Clin. Psychol. Rev. 12, 93-116.
49. Stark, M.J. and Kane, B.J. (1985) General and specific psychotherapy role induction for substance-abusing clients. Int. J. Addict. 20, 1135-1141.
50. Stephens, R.C., Feucht, T.E. and Gibbs, B.H. (1991) The impact of level of program intervention on the risk behavior of IVDUs in Cleveland. Research in Progress, NOVA Research Co., Washington, DC, October, pp. 22-26.
51. Stimmel, B., Goldberg, J., Cohen, M. and Rotkopf, E. (1978) Detoxification from methadone maintenance: risk factors associated with relapse to narcotic use. Ann. NY Acad. Sci. 311, 183-180.
52. Stitzer, M.L., Bickel, W.K., Bigelow., G.E. and Liebson, J.A. (1986) Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients. Drug Alcohol Depend. 18, 341-348.
53. Sufian, M., Friedman, S.R., Cuitis, R., Neaigus, A. and Stepherson, B. (1991) Organizing as a new approach to AIDS risk reduction for intravenous drug users. In: Cocaine, AIDS, and Intravenous Drug Use (Friedman, S.R., Lipton, D.L. and Stimmel, B., eds.), Hawthorn Press, New York, pp. 89-98.
54. Watters, J.K., Downing, M., Case, P., Lorvick, J., Cheng, Y. and Fergusson, B. (1990) AIDS prevention for intravenous drug users in the community: street-based education and risk reduction. Am. J. Community Psychol. 18, 587-596.
55. Weatherby, N.L., Needle, R., Cesari, C. et al. (1994) Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. J. Ed. Prog. Plan. 17, 347-355.
56. Wiebel, W., Quellet, L., Guydan, C. and Samairat, N. (1990) Cocaine injection as a predictor of HIV risk behaviours. VI International Conference on AIDS, San Francisco.
57. Woody, G., O'Hare, K., Mintz, J. and O'Brien, C. (1975) Rapid treatment intake: a method for increasing retention rate of heroin addicts seeking methadone treatment. Comprehensive Psychiatry 16, 165-169.
58. Woody, G.E., Metzger, D.S., McClelland, AT. et al. (1992) Two year incidence rates for HIV and HTLV-I/II among IDUs in- and out-of-methadone treatment. 54th Annual Scientific Meeting College on Problems of Drug Dependence, Keystone, Colorado.
59. Yancovitz, S., Des Jarlais, D., Peyser, N. et al. (1991) A randomized trial of an interim methadone clinic. Am. J. Public Health 81, 1185-1191.